U.S. Pharmacopeia Issues Statement on the Decision to Suspend FDA Approval of Mifepristone in the Alliance for Hippocratic Medicine V. U.S. Food and Drug Administration Case
April 11, 2023
April 11, 2023
ROCKVILLE, Maryland, April 11 (TNSgov) -- The U.S. Pharmacopeia, an organization that says it focuses on building trust in the supply of safe, quality medicines, issued the following news release on April 10, 2023:
The U.S. Pharmacopeia (USP) today issued a statement on the US District Court for the Northern District of Texas decision to suspend the U.S. Food and Drug Administration (FDA) approval of Mifepristone in the Alliance for Hippocratic Medicine v. U.S. Food and Drug Adminis . . .
The U.S. Pharmacopeia (USP) today issued a statement on the US District Court for the Northern District of Texas decision to suspend the U.S. Food and Drug Administration (FDA) approval of Mifepristone in the Alliance for Hippocratic Medicine v. U.S. Food and Drug Adminis . . .